) to buy from neutral.
Analyst William Plovanic says Smith & Nephew withdrew its rival $2.5 billion offer for medical-technology firm Centerpulse, removing near-term uncertainties regarding the bidding war for Centerpulse.
Plovanic thinks the news is positive for Zimmer, as Centerpulse has recommended to its shareholders to accept the highest bid --clearing the way for a merger of Zimmer and Centerpulse. He says Zimmer expects the deal to be accretive within the first year, excluding charges.
He notes Zimmer's $3 billion bid for Centerpulse will be open until Aug. 27. He doesn't see any changes to either bid at this time.